The landscape of peptide medicine is experiencing a remarkable shift with the rise of AMP (Accelerated Molecule Peptide) chains. These innovative compounds are crafted to swiftly traverse biological boundaries, offering the opportunity for greater drug distribution and specific therapeutic impact